Dr Martens investor calls for strategic review
Dr Martens shareholder Marathon Partners Equity Management is reportedly calling on the boot specialist to hire bankers and kick off a strategic review of the business, pre-empting a potential sale of the retailer.
In a letter seen by Reuters, the New York based investment firm said the “stalled earnings growth and sharp share price drop” of 83% since its public listing in 2021 have “decoupled its valuation from its intrinsic value”.
Already have an account? Sign in here